[HTML] nih.gov

[HTML][HTML] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - Oncotarget, 2014 - ncbi.nlm.nih.gov
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs
(lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We …
被引用次数：243 相关文章

Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue… - …, 2014 - pubmed.ncbi.nlm.nih.gov
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs
(lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We …
[PDF] semanticscholar.org

[PDF][PDF] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - pdfs.semanticscholar.org
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs
(lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We …
[PDF] open.ac.uk

[PDF][PDF] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - libeprints.open.ac.uk
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs
(lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We …

Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer.

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - Oncotarget, 2014 - europepmc.org
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs
(lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We …
[PDF] psu.edu

[PDF][PDF] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - Citeseer
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs
(lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We …
[HTML] oncotarget.com

[HTML][HTML] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - Oncotarget, 2014 - oncotarget.com
Abstract Francesco Crea 1, Akira Watahiki 1, 2, Luca Quagliata 3, Hui Xue 1, Larissa Pikor 4,
Abhijit Parolia 1, 5, Yuwei Wang 1, Dong Lin 1, 2, Wan L. Lam 4, William L. Farrar 6, Takao …
[PDF] scienceopen.com

[PDF][PDF] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - scienceopen.com
Metastatic prostate cancer (PCa) is still an incurable disease. Long non-coding RNAs
(lncRNAs) may be an overlooked source of cancer biomarkers and therapeutic targets. We …

[引用][C] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - Oncotarget, 2014 - folia.unifr.ch
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic
target for metastatic prostate cancer SONAR logo Log in Sign up EN English Français …

[引用][C] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer

F Crea, A Watahiki, L Quagliata, H Xue, L Pikor… - Oncotarget, 2014 - cir.nii.ac.jp
Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target
for metastatic prostate cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …